ABCMdb

ABCC1 p.Tyr440Phe

Predicted by SNAP2:	A: D (75%), C: D (63%), D: D (85%), E: D (85%), F: N (72%), G: D (85%), H: D (75%), I: D (59%), K: D (91%), L: D (75%), M: D (71%), N: D (80%), P: D (91%), Q: D (71%), R: D (91%), S: D (80%), T: D (80%), V: D (75%), W: D (66%),
Predicted by PROVEAN:	A: D, C: D, D: D, E: D, F: N, G: D, H: D, I: D, K: D, L: D, M: D, N: D, P: D, Q: D, R: D, S: D, T: D, V: D, W: D,

[switch to compact view]
Comments [show]

None has been submitted yet.

Publications
[hide] Structural determinants of substrate specificity d... Drug Metab Dispos. 2008 Dec;36(12):2571-81. Epub 2008 Sep 5. Grant CE, Gao M, DeGorter MK, Cole SP, Deeley RG
Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3).
Drug Metab Dispos. 2008 Dec;36(12):2571-81. Epub 2008 Sep 5., [PMID:18775981]

Abstract [show]
Multidrug resistance proteins (MRPs) are members of the "C" branch of the ATP-binding cassette transporter superfamily. Human MRP1 transports a wide range of natural product drugs and structurally diverse conjugated and unconjugated organic anions. Its closest relative is MRP3. Despite their structural similarity, the homologs differ substantially in their substrate specificity. It is noteworthy that MRP1 transports glutathione (GSH) and GSH conjugates and displays GSH-stimulated transport of a number of unconjugated and conjugated compounds. In contrast, MRP3 does not transport GSH and is a poor transporter of GSH conjugates. However, both proteins transport glucuronide conjugates, such as 17beta-estradiol 17-(beta-D-glucuronide). We have constructed a series of MRP1/MRP3 hybrids and used them to identify a region of MRP1 that is critical for binding and transport of GSH conjugates such as leukotriene C(4) (LTC(4)). Substitution of this region encompassing transmembrane helices 8 and 9 and portions of cytoplasmic loops 4 and 5 of MRP1 with the equivalent region of MRP3 eliminated LTC(4) transport. Transport of other substrates was either unaffected or enhanced. We identified three residues in this region: Tyr(440), Ile(441), and Met(443), mutation of which differentially affected transport. It is noteworthy that substitution of Tyr(440) with Phe, as found in MRP3, reduced LTC(4) and GSH-stimulated estrone-3-sulfate transport without affecting transport of other substrates tested. The mutation increased the K(m) for LTC(4) 5-fold and substantially reduced photolabeling of MRP1 by both [3H]LTC(4) and the GSH derivative, azidophenacyl-[35S]GSH. These results suggest that Tyr(440) makes a major contribution to recognition of GSH and the GSH moiety of conjugates such as LTC(4).

Comments [show]

None has been submitted yet.

Sentences [show]
No. Sentence Comment
13 It is noteworthy that substitution of Tyr440 with Phe, as found in MRP3, reduced LTC4 and GSH-stimulated estrone-3-sulfate transport without affecting transport of other substrates tested. Login to comment
138 The most dramatic reduction in transport was found for one double mutation located in the G1 region, Y440F/I441L, which reduced LTC4 transport to less than 20% of wild-type levels (Fig. 3B). Login to comment
142 With the exception of one triple mutation, in which substitution of M443 with L was introduced into the LTC4 transport-deficient Y440F/I441L double mutant, no combination of mutations tested reduced LTC4 transport by more than 60 to 70% (data not shown). Login to comment
143 The Y440F/I441L/M443L virtually eliminated LTC4 transport (Fig. 3B) but also reduced E217betaG transport by approximately 80% (Fig. 3C). Login to comment
144 Transport of LTC4, E217betaG, E13SO4, and MTX by Y440F, I441L, and M443L MRP1 Mutant Proteins. Login to comment
156 The Y440F and M443L mutations each independently decreased initial rates of LTC4 transport by approximately 60 and 50%, respectively, whereas the I441L mutation had little or no effect (Fig. 3B). Login to comment
157 In contrast, E217betaG transport was decreased approximately 50% by both the I441L and M443L mutations but only 20% by the Y440F mutation (Fig. 3C). Login to comment
158 All three mutations significantly decreased E13SO4 transport in the presence of 2 mM S-methyl GSH, with the Y440F, I441L, and M443L mutations reducing transport at 1 min by approximately 65, 50, and 90%, respectively (Fig. 3D). Login to comment
175 Kinetic Parameters of [3 H]LTC4 Transport by Y440F and I441L Single and Double Mutants. Login to comment
176 We also determined the effects of the Y440F and I441L single and double mutations on the Km and Vmax for LTC4 transport. Login to comment
177 The Km and Vmax values obtained for wild-type MRP1 were 72 nM and 37 pmol/mg/min, respectively, whereas the Km for the Y440F mutation was 328 nM and the normalized Vmax was 41 pmol/mg/min (Fig. 4, A and B). Login to comment
193 Mutations Included 23 M443L/Y440F/1441L 24 A481G/V482A/M483V/M485V 25 V479L/A481G/V482A/M483V/M485V 26 A493K/H494Q/S497L/N500S 27 V479L/A481G/V482A/M483V/M485V 28 V479L/A481G/V482A/M483V/N500S 29 A493K/H494Q/S497L/N500S/N506S 30 A493K/H494Q/S497L/N506S/T487M/K488R/T489A/Y490F consequence, it was technically impossible to determine an accurate Km for LTC4. Login to comment
195 To confirm whether the increase in Km resulting from the Y440F mutation reflected a decreased affinity for substrate, we examined the effect of the mutation on photolabeling of MRP1 with [3 H]LTC4. Login to comment
201 However, photolabeling of the NH2-terminal fragments of both the Y440F and double Y440F/I441L mutant proteins was similarly, substantially reduced compared with both the wild-type and the I441L mutant. Login to comment
203 Furthermore, photolabeling of the COOH-terminal fragment of the Y440F and Y440F/I441L mutant proteins was also reduced when compared with wild-type MRP1 or the I441L mutant, despite the fact that this region is identical in all four proteins. Login to comment
209 All of these mutations had a greater effect on transport than the more conservative Y440F mutation. Login to comment
213 In addition, unlike the Y440F mutation, which had little effect on E217betaG transport, the Y440W mutation essentially eliminated transport of the conjugated estrogen (Fig. 6B). Login to comment
215 The Y440F mutation has a major deleterious effect on the transport of LTC4 and the S-methyl GSH-stimulated transport of E13SO4 (Fig. 3, B and D) but not on the other estrogen conjugate tested (E217betaG) or MTX (Fig. 3, C and E). Login to comment
216 Because we have shown that the Y440F mutant protein has reduced affinity for LTC4 compared with wild-type MRP1 (Fig. 4B), it is possible that the Y440F mutation also affects the affinity for E13SO4 and/or S-methyl GSH. Login to comment
217 To test the former hypothesis, we attempted to determine a Km for the transport of E13SO4 by wild-type MRP1 and the Y440F mutant. Login to comment
222 Shown are wild-type MRP1 (f), Y440F (Œ), I441L (), and Y440F/I441L (ࡗ). Login to comment
226 [3 H]LTC4 photolabeling of membrane vesicle isolated from Sf21 cells expressing wild-type and mutant MRP1 proteins. A, immunoblot showing the relative amounts of MRP1 protein in each sample after adjustment for relative MRP1 protein expression; wild-type MRP1 (35 ␮g) and mutants Y440F (75 ␮g), I441L (22 ␮g), and Y440F/I441L (20 ␮g). Login to comment
233 To test whether the Y440F mutation alters the binding characteristics of S-methyl GSH and thus E13SO4 transport, we examined the binding of a GSH analog, azidophenacyl-GSH, to wild-type and mutant MRP1 expressed in stably transfected HEK cells. Login to comment
239 In contrast, the Y440F mutation, which reduced S-methyl GSH-stimulated transport of E13SO4 by approximately 65% (Fig. 3D), markedly decreased photolabeling with azidophenacyl-[35 S]GSH (Fig. 7C). Login to comment
240 This suggests that the affinity for this GSH derivative is dramatically affected by the Y440F mutation, as was found for LTC4. Login to comment
241 The reduced affinity for both azidophenacyl GSH and LTC4 suggests that the Y440F mutation may alter the interaction of MRP1 with the GSH moiety of both compounds and thus may decrease E13SO4 transport by reducing the affinity for GSH and S-methyl GSH. Login to comment
242 Effect of the Y440F, I441L, M443L, and Y440F/I441L Mutations on Resistance to Vincristine, Doxorubicin, and VP-16. Login to comment
243 Lastly, the drug-resistance profiles of Y440F, I441L, M443L, and Y440F/I441L mutant proteins were examined because unlike MRP1, the profile of resistance to natural product drugs conferred by MRP3 is restricted primarily to epipodophyllotoxins (Deeley et al., 2006). Login to comment
260 The three single mutations each decreased resistance to vincristine and VP-16, 2-to 3-fold, whereas only the Y440F mutation resulted in a major decrease in resistance to doxorubicin. Login to comment
261 The effect of the double Y440F/I441I mutation seemed to be additive with respect to both VP-16 and doxorubicin resistance but resulted in no greater decrease in resistance to vincristine than either mutation alone. Login to comment
280 It is noteworthy that conservative substitution of Tyr440 with Phe as present in MRP3 reduced LTC4 transport by ϳ60% with little effect on transport of E217betaG. Login to comment
282 The Y440F mutation resulted in a significant decrease in the apparent affinity for LTC4 (4-5-fold increase in Km), whereas Vmax was not affected. Login to comment
283 In addition, photolabeling of the Y440F protein by [3 H]LTC4 was markedly decreased. Login to comment
284 Taken together, the data strongly suggested that the primary defect in the Y440F protein was at the level of LTC4 binding. Login to comment
292 In particular, the relatively conservative substitution with Trp not only decreased LTC4 transport by ϳ75%, but unlike the Y440F mutation, also essentially eliminated transport of E217betaG. Login to comment
295 In contrast to the Y440F mutation, the conservatively substituted I441L mutation had no effect on LTC4 or MTX transport but decreased transport of both E217betaG and E13SO4, whereas the M443L mutation decreased transport of all three conjugated substrates but not TABLE 2 Relative Drug Resistance of HEK293 Cells Transfected with Wild-Type and Mutant MRP1 Transfectant Drug (Relative Resistance Factora ) Vincristine VP-16 Doxorubicin HEKMRP1 15.6 Ϯ 2.5 16.2 Ϯ 4.9 4.5 Ϯ 0.3 HEKMRP1-Y440F 2.4 Ϯ 0.5 (5.1) 2.7 Ϯ 0.8 (6.0) 1.3 Ϯ 0.2 (1.9) HEKMRP1-1441L 8.9 Ϯ 2.5 (9.7) 4.1 Ϯ 1.2 (4.4) 3.7 Ϯ 1.4 (4.1) HEKMRP1-M443L 6.5 Ϯ 1.2 (6.0) 5.8 Ϯ 0.5 (5.4) 3.8 Ϯ 0.7 (3.6) HEKMRP1-Y440F/1441L 3.9 Ϯ 1.0 (7.5) 1.3 Ϯ 0.3 (1.7) 1.2 Ϯ 0.2 (1.5) HEKMRP3 1.1 Ϯ 0.1 6.4 Ϯ 1.9 0.87 Ϯ 0.2 a The relative resistance factor was obtained by dividing the IC50 values for the wild-type or mutant MRP1-transfected cells by the IC50 value for cells transfected with the expression vector alone. Login to comment
303 Most significantly, the conservative substitution of Lys332 by Arg increased the Km for LTC4 ϳ5-fold without affecting the Vmax, as is the case with the Y440F mutation. Login to comment
307 The Y440F mutation had little effect on either E217betaG or MTX transport but markedly decreased S-methyl GSH-stimulated E13SO4 transport, and photolabeling with the GSH analog azidophenacyl- [35 S]GSH was severely reduced. Login to comment
309 However, it is clear that the Y440F mutation almost entirely eliminates binding of azidophenacyl-GSH, as well as LTC4. Login to comment
311 Consistent with this suggestion, the Y440F mutation resulted in a major decrease in resistance to all three classes of drugs, transport of, or resistance to which, has been shown to be GSH-dependent (Loe et al., 1996b, 1998; Rappa et al., 1997; Renes et al., 1999). Login to comment

[hide] Structural and functional properties of human mult... Curr Med Chem. 2011;18(3):439-81. He SM, Li R, Kanwar JR, Zhou SF
Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1).
Curr Med Chem. 2011;18(3):439-81., [PMID:21143116]

Abstract [show]
Multidrug ABC transporters such as P-glycoprotein (P-gp/MDR1/ABCB1) and multidrug resistance protein 1 (MRP1/ABCC1) play an important role in the extrusion of drugs from the cell and their overexpression can be a cause of failure of anticancer and antimicrobial chemotherapy. Recently, the mouse P-gp/Abcb1a structure has been determined and this has significantly enhanced our understanding of the structure-activity relationship (SAR) of mammalian ABC transporters. This paper highlights our current knowledge on the structural and functional properties and the SAR of human MRP1/ABCC1. Although the crystal structure of MRP1/ABCC1 has yet to be resolved, the current topological model of MRP1/ABCC1 contains two transmembrane domains (TMD1 and TMD2) each followed by a nucleotide binding domain (NBD) plus a third NH2-terminal TMD0. MRP1/ABCC1 is expressed in the liver, kidney, intestine, brain and other tissues. MRP1/ABCC1 transports a structurally diverse array of important endogenous substances (e.g. leukotrienes and estrogen conjugates) and xenobiotics and their metabolites, including various conjugates, anticancer drugs, heavy metals, organic anions and lipids. Cells that highly express MRP1/ABCC1 confer resistance to a variety of natural product anticancer drugs such as vinca alkaloids (e.g. vincristine), anthracyclines (e.g. etoposide) and epipodophyllotoxins (e.g. doxorubicin and mitoxantrone). MRP1/ABCC1 is associated with tumor resistance which is often caused by an increased efflux and decreased intracellular accumulation of natural product anticancer drugs and other anticancer agents. However, most compounds that efficiently reverse P-gp/ABCB1-mediated multidrug resistance have only low affinity for MRP1/ABCC1 and there are only a few effective and relatively specific MRP1/ABCC1 inhibitors available. A number of site-directed mutagenesis studies, biophysical and photolabeling studies, SAR and QSAR, molecular docking and homology modeling studies have documented the role of multiple residues in determining the substrate specificity and inhibitor selectivity of MRP1/ABCC1. Most of these residues are located in the TMs of TMD1 and TMD2, in particular TMs 4, 6, 7, 8, 10, 11, 14, 16, and 17, or in close proximity to the membrane/cytosol interface of MRP1/ABCC1. The exact transporting mechanism of MRP1/ABCC1 is unclear. MRP1/ABCC1 and other multidrug transporters are front-line mediators of drug resistance in cancers and represent important therapeutic targets in future chemotherapy. The crystal structure of human MRP1/ABCC1 is expected to be resolved in the near future and this will provide an insight into the SAR of MRP1/ABCC1 and allow for rational design of anticancer drugs and potent and selective MRP1/ABCC1 inhibitors.

Comments [show]

None has been submitted yet.

Sentences [show]
No. Sentence Comment
792 The Tyr440Phe mutant expressed in Sf21 cells showed a 5-fold higher Km for LTC4 and substantially reduced photolabeling of MRP1/ABCC1 by both [3 H]LTC4 and the GSH derivative, azidophenacyl-[35 S]GSH [374]. Login to comment
794 In addition, the Tyr440Phe, Ile441Leu, Met443Leu mutations decreased resistance to vincristine and etoposide 2-to 3-fold, whereas only the Tyr440Phe mutant displayed a major decrease in resistance to doxorubicin [374]. Login to comment